How To Succeed In Your Business Networking Though Multilingual Webinars In The New Normal 
ECLIPSE CROSS PHEV and Gasoline Options Now Available In Japan 
NEC to Introduce “Banks of the Future” at SFF x SWITCH 2020 
Olympus Grows Respiratory Portfolio with Acquisition of Veran Medical Technologies, Inc. 
Eisai to Present Abstracts on Oncology Products and Pipeline at 43rd Annual San Antonio Breast Cancer Symposium Genmab Announces that Janssen has Submitted a Biologics License Application to U.S. FDA for Amivantamab in Non-small Cell Lung Cancer
Media Release Copenhagen, Denmark, December 3, 2020 Janssen submitted a BLA to U.S. FDA…
Tauriga Sciences, Inc. Introduces its Product Line of CBD Infused Bath Bombs Under the Tauri-Gum Brand
December 3 PR Blood Orange Fragrance Tauri-Gum™ Branded Bath Bomb The Company has Launched its…
Akari Therapeutics Announces Publication in American Journal of Pathology Highlighting Potential of Nomacopan in Treatment of Uveitis and Retinal Disease
New data highlight role of leukotriene B4 (LTB4) in the pathophysiology of retinal inflammation and…
Annovis Bio to Present at the New York Academy of Sciences’ Alzheimer’s Disease Therapeutics: Alternatives to Amyloid 2020 Virtual Conference
BERWYN, Pa., Dec. 03, 2020 (GLOBE NEWSWIRE) — Annovis Bio Inc. (NYSE American: ANVS), a…
Intrivo Diagnostics Inks National Distribution Agreements with Concordance Healthcare Solutions and NDC for Access Bio CareStart™ COVID-19 Tests
Major supply chain agreements will ensure broad access to rapid testing solutions for patients and…
Taconic Biosciences Expands Innovative ExpressMODEL® Portfolio
New Random Integration Transgenic Animal Model Generation Solution Available RENSSELAER, New York, Dec. 03, 2020…
AXIM® Biotechnologies Develops ELISA-Based Neutralizing Antibody Diagnostic Test for COVID-19 and Applies for Patent; Company’s Fourth COVID-19 Test-Focused Patent Application
SAN DIEGO, Dec. 03, 2020 (GLOBE NEWSWIRE) — AXIM® Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” “AXIM”…
Parexel Named Best Contract Research Organization by Scrip
Company recognized for innovative and effective use of real-world data and flexible trial designs BOSTON…
Syneos Health and ConcertAI Announce Strategic Collaboration to Accelerate the Use of Real World Evidence and AI to Advance Oncology Research
Combination Offers Customers Access to Largest U.S. Oncology Real World Data Source and Best-in-Class Product…
Innate Pharma to Present Additional Efficacy Data for Monalizumab in Combination With Cetuximab in Head and Neck Cancer at the ESMO Immuno-Oncology Virtual Congress
Phase 2 expansion cohort data supports ongoing Phase 3 trial MARSEILLE, France, Dec. 03, 2020…